Q4FY21 | Sequent Scientific Notes

Sequent 2.0

High Level Notes

  1. India business doubled from 39 cr. to 78 cr. driven by two factors - underlying growth of existing products and commercialisation of Zoetis portfolio

  2. Company has laid out a chart for making ~200 cr. in investments in the next 2 years and renew focus on India, Turkey and Brazil

  3. An advisory board has been put into place to help the company …

This post is for paying subscribers